Answers are grounded in this paper and cite their sources.
Erythromycin is not currently recognized as causing clinical aggravation of myasthenia gravis. We report the case of a patient who experienced exacerbations of myasthenia gravis subsequent to each of several doses of intravenous erythromycin. We suggest that erythromycin can cause clinical worsening in patients with disease of the neuromuscular junction.
No takes yet. Share an insight, caveat, or question.
May et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: